Group 1 - The first extraordinary general meeting of shareholders for Jianmin Pharmaceutical Group Co., Ltd. is scheduled for July 30, 2025, at 14:00 in Wuhan [1][2] - The meeting will combine on-site voting and online voting through the Shanghai Stock Exchange's shareholder meeting voting system [4][7] - The agenda includes the review and voting on the proposal to amend the company's articles of association [8][9] Group 2 - The meeting will be presided over by Vice Chairman Xu Liang, with Secretary of the Board Zhou Jie recording the minutes [1][2] - Shareholders or their legal representatives must register 30 minutes before the meeting and present necessary identification [6] - The voting process will include a break, followed by the announcement of voting results after the market closes at 15:00 [2][5] Group 3 - The proposed amendments to the articles of association aim to enhance corporate governance by removing the supervisory board and transferring its responsibilities to the audit committee [8][9] - New sections will clarify the roles and obligations of controlling shareholders and actual controllers, as well as the responsibilities of independent directors [9][21] - The amendments will also standardize the procedures for convening shareholder meetings and clarify the qualifications for directors and senior management [9][10]
健民集团: 健民集团2025年第一次临时股东大会会议资料